120 related articles for article (PubMed ID: 23162107)
1. Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray study.
Prins MJ; Verhage RJ; Ruurda JP; ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2013 Mar; 66(3):224-8. PubMed ID: 23162107
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
[TBL] [Abstract][Full Text] [Related]
5. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
Sun CH; Chang YH; Pan CC
Histopathology; 2011 Jun; 58(7):1054-63. PubMed ID: 21707707
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
7. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of TSC1 and mTOR expression in gastric carcinoma.
Byeon SJ; Han N; Choi J; Kim MA; Kim WH
J Surg Oncol; 2014 Jun; 109(8):812-7. PubMed ID: 24615476
[TBL] [Abstract][Full Text] [Related]
9. Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.
Fahmy M; Mansure JJ; Brimo F; Yafi FA; Segal R; Althunayan A; Hicks J; Meeker A; Netto G; Kassouf W
Hum Pathol; 2013 Sep; 44(9):1766-72. PubMed ID: 23623586
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated mTOR expression is associated with poor prognosis for patients with esophageal squamous cell carcinoma.
Hirashima K; Baba Y; Watanabe M; Karashima R; Sato N; Imamura Y; Hiyoshi Y; Nagai Y; Hayashi N; Iyama K; Baba H
Ann Surg Oncol; 2010 Sep; 17(9):2486-93. PubMed ID: 20339946
[TBL] [Abstract][Full Text] [Related]
11. Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma.
Liu D; Huang Y; Chen B; Zeng J; Guo N; Zhang S; Liu L; Xu H; Mo X; Li W
Cancer; 2011 Aug; 117(16):3763-73. PubMed ID: 21387259
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
[TBL] [Abstract][Full Text] [Related]
13. mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
Boone J; Ten Kate FJ; Offerhaus GJ; van Diest PJ; Rinkes IH; van Hillegersberg R
J Clin Pathol; 2008 Aug; 61(8):909-13. PubMed ID: 18474542
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
15. Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer.
Yoshida Y; Kurokawa T; Horiuchi Y; Sawamura Y; Shinagawa A; Kotsuji F
Eur J Cancer; 2010 Dec; 46(18):3445-52. PubMed ID: 20926288
[TBL] [Abstract][Full Text] [Related]
16. Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma.
Darwish OM; Kapur P; Youssef RF; Bagrodia A; Belsante M; Alhalabi F; Sagalowsky AI; Lotan Y; Margulis V
Urology; 2013 Mar; 81(3):581-6. PubMed ID: 23290145
[TBL] [Abstract][Full Text] [Related]
17. mTOR-RAPTOR and 14-3-3σ immunohistochemical expression in high grade prostatic intraepithelial neoplasia and prostatic adenocarcinomas: a tissue microarray study.
Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
J Clin Pathol; 2011 Aug; 64(8):683-8. PubMed ID: 21653658
[TBL] [Abstract][Full Text] [Related]
18. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
Anagnostou VK; Bepler G; Syrigos KN; Tanoue L; Gettinger S; Homer RJ; Boffa D; Detterbeck F; Rimm DL
Clin Cancer Res; 2009 Jun; 15(12):4157-64. PubMed ID: 19509151
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification study.
Gately K; Al-Alao B; T Dhillon ; Mauri F; Cuffe S; Seckl M; O'Byrne K
Lung Cancer; 2012 Feb; 75(2):217-22. PubMed ID: 21802763
[TBL] [Abstract][Full Text] [Related]
20. The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clinicopathologic implications.
Fadare O; Renshaw I; Olson SJ; Liang SX
Int J Gynecol Pathol; 2011 May; 30(3):244-51. PubMed ID: 21464729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]